AW

Abdul Wahab Jaleel

Director Director DIN 09347584
DIN 09347584 First appointment Oct 2021 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Oct 2021
Shareholding value Locked Premium profile

About Abdul Wahab Jaleel

Data last updated:

Abdul Wahab Jaleel has 5 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

DIN 09347584
Primary Designation Director
First Appointment 07 Oct 2021
Oldest Company Age 5 yrs

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Nexcure Pharma Private Limited U24230KA2021PTC146637
Director07 Oct 20212021Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Nexcure Pharma Private Limited
Premium access

Shareholding and investment profile for Abdul Wahab Jaleel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abdul Wahab Jaleel

Abdul Wahab Jaleel has 5 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

Abdul Wahab Jaleel is associated with 0 companies as Director.

Abdul Wahab Jaleel has expertise in General Business.

Abdul Wahab Jaleel has 5 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available